Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section
NCT02787928Phase 1Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- Apr 2016
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hydromorphone in postoperative pain, sponsored by Virginia Commonwealth University. Primary endpoint: Requirement for Additional Narcotic Pain Medication at 12 hours. Started Apr 2016; status: terminated.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02787928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787928.